Ghost Tree Capital »

Rezolute shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of Rezolute (RZLT) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in Rezolute

Tip: Access up to 7 years of quarterly data

All positions including Rezolute held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rezolute by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $6.1M 1.4M 4.30

More positions owned by Ghost Tree Capital

Alnylam Pharmaceuticals (ALNY)
Insmed Com Par $.01 (INSM)
Biohaven (BHVN)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Soleno Therapeutics (SLNO)
Axsome Therapeutics (AXSM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Vaxcyte (PCVX)
Crinetics Pharmaceuticals In (CRNX)
Roivant Sciences SHS (ROIV)
Perspective Therapeutics Com New (CATX)
Tg Therapeutics (TGTX)
Sarepta Therapeutics (SRPT)
Cg Oncology (CGON)
Corbus Pharmaceuticals Hldgs Com New (CRBP)

View all positions for Ghost Tree Capital

Top funds holding Rezolute

Federated Investors
Nantahala Capital Management
Affinity Asset Advisors
Blackstone Group
Sphera Funds Management
Altium Capital Management
Vanguard Group
Ghost Tree Capital
Alyeska Investment Group
Marshall Wace
Ikarian Capital
Morgan Stanley
BlackRock
Geode Capital Management
Citadel Advisors

View all funds holding Rezolute